Literature DB >> 8797716

Genetic variability and molecular epidemiology of human and simian T cell leukemia/lymphoma virus type I.

A Gessain1, R Mahieux, G de Thé.   

Abstract

In the past few years, numerous investigators have demonstrated that human T cell leukemia/lymphoma virus type I (HTLV-I) possesses a great genetic stability, and recent data indicate that viral amplification via clonal expansion of infected cells, rather than by reverse transcription, could explain this remarkable genetic stability. In parallel, the molecular epidemiology of HTLV-I proviruses showed that the few nucleotide changes observed between isolates were specific for the geographical origin of the patients but not for the type of the associated pathologies (adult T cell leukemia/lymphoma, tropical spastic paraparesis/HTLV-I-associated myelopathy). Thus, based on sequence and/or restriction fragment length polymorphism analysis of more than 250 HTLV-I isolates originating from the main viral endemic areas, three major molecular geographical subtypes (or genotypes) emerged, strongly supported by phylogenetic analysis (high bootstrap values). Each of these genotypes (Cosmopolitan, Central African, and Melanesian) appeared to arise from ancient interspecies transmission between monkeys infected with simian T cell leukemia/lymphoma virus type I and humans. Furthermore, careful sequences analyses indicate that, within (or alongside) these three main genotypes, there are molecular subgroups defined clearly by several specific mutations but not always supported by phylogenetic analyses. Thus in Japan, there is evidence for two ancestral HTLV-I lineages: the classical Cosmopolitan genotype, representing approximately 25% of the HTLV-I present in Japan and clustering in the southern islands; and a related subgroup that we called the Japanese group. Similarly, within the Central African cluster, there are molecular subgroups defined by specific substitutions in either the env or the long terminal repeat. Furthermore, recent data from our laboratory indicate the presence of a new molecular phylogenetic group (fourth genotype) found among inhabitants of Central Africa, particularly in Pygmies. While geographical subtypes vary from 2 to 8% between themselves, HTLV-I quasi-species present within an individual appear to be much lower, with a variability of < 0.5%.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8797716     DOI: 10.1097/00042560-199600001-00022

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr Hum Retrovirol        ISSN: 1077-9450


  14 in total

1.  Human T cell leukaemia/lymphoma virus infection in pregnant women in the United Kingdom: population study.

Authors:  A E Ades; S Parker; J Walker; M Edginton; G P Taylor; J N Weber
Journal:  BMJ       Date:  2000-06-03

2.  Emergence of a novel and highly divergent HTLV-3 in a primate hunter in Cameroon.

Authors:  HaoQiang Zheng; Nathan D Wolfe; David M Sintasath; Ubald Tamoufe; Matthew Lebreton; Cyrille F Djoko; Joseph Le Doux Diffo; Brian L Pike; Walid Heneine; William M Switzer
Journal:  Virology       Date:  2010-03-30       Impact factor: 3.616

3.  Human T-lymphotropic virus type 1 mitochondrion-localizing protein p13II sensitizes Jurkat T cells to Ras-mediated apoptosis.

Authors:  Hajime Hiraragi; Bindhu Michael; Amrithraj Nair; Micol Silic-Benussi; Vincenzo Ciminale; Michael Lairmore
Journal:  J Virol       Date:  2005-08       Impact factor: 5.103

4.  Genetic stability of foamy viruses: long-term study in an African green monkey population.

Authors:  M Schweizer; H Schleer; M Pietrek; J Liegibel; V Falcone; D Neumann-Haefelin
Journal:  J Virol       Date:  1999-11       Impact factor: 5.103

5.  Molecular Biology and Diversification of Human Retroviruses.

Authors:  Morgan E Meissner; Nathaniel Talledge; Louis M Mansky
Journal:  Front Virol       Date:  2022-06-02

6.  High seroprevalence of human T-cell lymphotropic virus type 1 in blood donors in Guyana and molecular and phylogenetic analysis of new strains in the Guyana shelf (Guyana, Suriname, and French Guiana).

Authors:  Jean-François Pouliquen; Lynette Hardy; Anne Lavergne; Eric Kafiludine; Mirdad Kazanji
Journal:  J Clin Microbiol       Date:  2004-05       Impact factor: 5.948

7.  New insights into prevalence, genetic diversity, and proviral load of human T-cell leukemia virus types 1 and 2 in pregnant women in Gabon in equatorial central Africa.

Authors:  Sonia Lekana-Douki Etenna; Mélanie Caron; Guillaume Besson; Maria Makuwa; Antoine Gessain; Antoine Mahé; Mirdad Kazanji
Journal:  J Clin Microbiol       Date:  2008-09-24       Impact factor: 5.948

8.  Simian T-cell lymphotropic virus type 1 from Mandrillus sphinx as a simian counterpart of human T-cell lymphotropic virus type 1 subtype D.

Authors:  R Mahieux; C Chappey; M C Georges-Courbot; G Dubreuil; P Mauclere; A Georges; A Gessain
Journal:  J Virol       Date:  1998-12       Impact factor: 5.103

Review 9.  Molecular determinants of human T-lymphotropic virus type 1 transmission and spread.

Authors:  Michael D Lairmore; Rajaneesh Anupam; Nadine Bowden; Robyn Haines; Rashade A H Haynes; Lee Ratner; Patrick L Green
Journal:  Viruses       Date:  2011-07-12       Impact factor: 5.048

10.  Cellular Factors Involved in HTLV-1 Entry and Pathogenicit.

Authors:  Hiroo Hoshino
Journal:  Front Microbiol       Date:  2012-06-21       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.